Financhill
Back

Robert Half Vs. Cytokinetics Industry Stock Comparison

Sell
28

RHI
Robert Half

Last Price:
64.83
Seasonality Move:
3.77%
Buy
55

CYTK
Cytokinetics

Last Price:
53.96
Seasonality Move:
7.55%
Sell
28
Robert Half (RHI) is a Sell

Is Robert Half a Buy, Sell or Hold?

  • The current Robert Half [RHI] share price is $64.83. The Score for RHI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RHI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RHI Stock Price Chart

What is Robert Half's stock price today?

  • The Robert Half share price today is $64.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHI is experiencing slight buying pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

RHI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.7 Sell
Relative Strength Index (14 RSI): 40.54 Sell
Chaikin Money Flow: 465383 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.21 - 69.61) Sell
Bollinger Bands (100): (68.15 - 80.49) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: 781761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.51 - 58.99) Sell
Bollinger Bands (100): (57.71 - 76.51) Sell

RHI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.49 Buy
20-day SMA: 65.23 Sell
50-day SMA: 68.77 Sell
200-day SMA: 76.43 Sell
8-day EMA: 64.03 Buy
20-day EMA: 65.27 Sell
50-day EMA: 68.72 Sell
200-day EMA: 74.83 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.47 Buy
20-day SMA: 52.83 Buy
50-day SMA: 60.85 Sell
200-day SMA: 55.3 Sell
8-day EMA: 53.07 Buy
20-day EMA: 54.08 Sell
50-day EMA: 58.8 Sell
200-day EMA: 57.11 Sell

Robert Half Earnings Growth & RHI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.90 per share, and an increase next year of $1.05 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

Robert Half Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):